154 related articles for article (PubMed ID: 15620452)
41. In vitro efficacy of 5 antifungal agents against Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis as determined by time-kill methodology.
Szabó Z; Szilágyi J; Tavanti A; Kardos G; Rozgonyi F; Bayegan S; Majoros L
Diagn Microbiol Infect Dis; 2009 Jul; 64(3):283-8. PubMed ID: 19394787
[TBL] [Abstract][Full Text] [Related]
42. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002.
Yang YL; Li SY; Cheng HH; Lo HJ;
Diagn Microbiol Infect Dis; 2005 Mar; 51(3):179-83. PubMed ID: 15766603
[TBL] [Abstract][Full Text] [Related]
43. Microbial profile and drug resistance of Candida strains isolated from the blood of children: an 11-year study.
Małafiej E; Adamiec AC; Tworzyańska U
Mycoses; 2009 Mar; 52(2):149-53. PubMed ID: 18627468
[TBL] [Abstract][Full Text] [Related]
44. Molecular epidemiology of Candida species isolated from urine at an intensive care unit.
Ergon MC; Gülay Z
Mycoses; 2005 Mar; 48(2):126-31. PubMed ID: 15743431
[TBL] [Abstract][Full Text] [Related]
45. Susceptibility to antifungal agents of Candida species isolated from paediatric and adult patients with haematological diseases.
Nawrot U; Nowicka J; Juszczak K; Gusin B
Mycoses; 2005 Nov; 48(6):385-90. PubMed ID: 16262874
[TBL] [Abstract][Full Text] [Related]
46. Risk factors for Candida species colonization of neonatal intensive care unit patients.
Saiman L; Ludington E; Dawson JD; Patterson JE; Rangel-Frausto S; Wiblin RT; Blumberg HM; Pfaller M; Rinaldi M; Edwards JE; Wenzel RP; Jarvis W;
Pediatr Infect Dis J; 2001 Dec; 20(12):1119-24. PubMed ID: 11740316
[TBL] [Abstract][Full Text] [Related]
47. Trends in candidemia and antifungal susceptibility in a university hospital in Northern Ireland 2001-2006.
Metwally L; Walker MJ; Coyle PV; Hay RJ; Hedderwick S; McCloskey BV; O'Neill HJ; Webb CH; McMullan R
J Infect; 2007 Aug; 55(2):174-8. PubMed ID: 17560655
[TBL] [Abstract][Full Text] [Related]
48. In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest.
Fleck R; Dietz A; Hof H
J Antimicrob Chemother; 2007 Apr; 59(4):767-71. PubMed ID: 17293369
[TBL] [Abstract][Full Text] [Related]
49. High colonization by Candida parapsilosis sensu stricto on hands and surfaces in an adult intensive care unit.
da Silva EM; Sciuniti Benites Mansano E; de Souza Bonfim-Mendonça P; Olegário R; Tobaldini-Valério F; Fiorini A; Svidzinski TIE
J Mycol Med; 2021 Jun; 31(2):101110. PubMed ID: 33450538
[TBL] [Abstract][Full Text] [Related]
50. [Impact of antifungal prophylaxis on the gastrointestinal yeast colonisation in patients with haematological malignancies].
Rimek D; Redetzke K; Kappe R
Mycoses; 2006; 49 Suppl 2():18-23. PubMed ID: 17022757
[TBL] [Abstract][Full Text] [Related]
51. Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management.
Chen SC; Marriott D; Playford EG; Nguyen Q; Ellis D; Meyer W; Sorrell TC; Slavin M;
Clin Microbiol Infect; 2009 Jul; 15(7):662-9. PubMed ID: 19614718
[TBL] [Abstract][Full Text] [Related]
52. Molecular epidemiology of Candida species isolated from clinical specimens of intensive care unit patients.
Marol S; Yücesoy M
Mycoses; 2008 Jan; 51(1):40-9. PubMed ID: 18076594
[TBL] [Abstract][Full Text] [Related]
53. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
[TBL] [Abstract][Full Text] [Related]
54. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.
Hachem R; Hanna H; Kontoyiannis D; Jiang Y; Raad I
Cancer; 2008 Jun; 112(11):2493-9. PubMed ID: 18412153
[TBL] [Abstract][Full Text] [Related]
55. Comment on reply of Miranda et al., Re: 'is the endogenous pathogenesis of Candida parapsilosis infection underreported?'.
Damjanovic V; Damjanovic CM; Taylor N; van Saene HK
J Hosp Infect; 2010 Feb; 74(2):187-8; author reply 188-9. PubMed ID: 20061063
[No Abstract] [Full Text] [Related]
56. Potential association of specific Candida parapsilosis genotypes, bloodstream infections and colonization of health workers' hands.
Delfino D; Scordino F; Pernice I; Lo Passo C; Galbo R; David A; Barberi I; Criseo G; Cascio A; Romeo O
Clin Microbiol Infect; 2014 Nov; 20(11):O946-51. PubMed ID: 24845557
[TBL] [Abstract][Full Text] [Related]
57. Candida parapsilosis, an emerging fungal pathogen.
Trofa D; Gácser A; Nosanchuk JD
Clin Microbiol Rev; 2008 Oct; 21(4):606-25. PubMed ID: 18854483
[TBL] [Abstract][Full Text] [Related]
58. Influence of the hospital environment on yeast colonization in nursing students.
Bonassoli LA; Svidzinski TI
Med Mycol; 2002 Jun; 40(3):311-3. PubMed ID: 12146762
[TBL] [Abstract][Full Text] [Related]
59. Yeast carriage on hands of hospital personnel working in intensive care units.
Huang YC; Lin TY; Leu HS; Wu JL; Wu JH
J Hosp Infect; 1998 May; 39(1):47-51. PubMed ID: 9617684
[TBL] [Abstract][Full Text] [Related]
60. Candida infection and colonization among trauma patients.
Manolakaki D; Velmahos G; Kourkoumpetis T; Chang Y; Alam HB; De Moya MM; Mylonakis E
Virulence; 2010; 1(5):367-75. PubMed ID: 21178472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
